Safe Save Medical Cell Sciences & Technology Co., Ltd.
Update：2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
"Autologous Dendritic Cell/ Tumor Antigen" ADCTA cancer immunotherapy
Founded Year
2011
Unified Business No.
53527046
Status
Active
Number of Employees
17
Total Paid-in
Capital
699,860,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Website
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
SSC, Safe Save Medical Cell Sciences & Technology CO., Ltd was founded in 2011, engaged in the development of cancer immunotherapy, owns the technology of autologous Dendritic Cells/Tumor Antigens (ADCTA) immunotherapy, and develops autologous immune tailor made precision medicine, is the benchmark of immunotherapy industry in Taiwan.
Safe Save Cell adheres to the corporate philosophy of "R&D innovation, excellent quality and professional service". Combining advanced research and development, technology platform, business model and Industry-Governor-Academia collaboration, Safe Save Cell established in Taiwan and are ambitious to be the global medicine provider and embark ourselves the leading company in dendritic cell immunotherapy in the world.
Safe Save Cell adheres to the corporate philosophy of "R&D innovation, excellent quality and professional service". Combining advanced research and development, technology platform, business model and Industry-Governor-Academia collaboration, Safe Save Cell established in Taiwan and are ambitious to be the global medicine provider and embark ourselves the leading company in dendritic cell immunotherapy in the world.
